Ads
related to: sava stock price forecast 30 days in advancesignup.chaikinanalytics.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
As I discussed in my last article on Cassava Sciences (NASDAQ:SAVA), controversy continues to weigh on the performance of SAVA stock. Over the past week, shares in the clinical-stage biotech firm ...
Cassava Sciences (NASDAQ:SAVA) stock took off once again during September. Rumors about the Securities and Exchange Commission (or SEC) clearing its investigation of the scandal-tarnished biotech ...
Six months ago Cassava Sciences (SAVA) had a problem. A citizen petition was logged with the FDA calling for a halt on the company's simufilam drug for the treatment of Alzheimer's Disease. The ...
Skip to main content. News
The stock market is full of ups and downs, which isn’t necessarily a bad thing. Shares of clinical-stage biotechnology company Cassava Sciences (NASDAQ:SAVA) are prone to peaks and valleys, but ...
Yet while SAVA stock has been acting less wild, don’t blame it on a lack of new developments. As InvestorPlace’s Eddie Pan reported Oct. 13, the biotech firm has announced plans to hold an ...